Transaction #21934 · Form 4 · 0001628280-25-057685
CRESCENT BIOPHARMA, INC. · Stock award · Stock Option (Right to Buy)
CRESCENT BIOPHARMA, INC. · Transacted December 15, 2025 · Filed December 17, 2025
What does this filing report?
An SEC Form 4 filing for CRESCENT BIOPHARMA, INC. records a stock award involving Stock Option (Right to Buy) on December 15, 2025. The reported quantity was 58,855. The filing date is December 17, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CRESCENT BIOPHARMA, INC.
- Company CIK
- 0001253689
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 58,855
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 58,855
- Ownership description
- Not reported
- SEC acceptance time
- Dec 17, 2025, 4:47 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Doughty Christopher Grant ↗
Chief Business Officer
CIK 0002074223
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Ordinary Shares
- Underlying quantity
- 58,855
- Conversion / exercise price
- 13.21
- Exercise date
- Not reported
- Expiration date
- December 15, 2035
Filing footnotes & remarks
- F1
- Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
- F2
- This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.